PKPlus™ Will Provide Analysis Capability Required for Regulatory Submissions
FDA’s Office of New Drug Products Places Order for 50 Additional Licenses to GastroPlus™
Additional Licenses Required to Meet Increasing Number of Submissions Utilizing GastroPlus
Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2015
Company Reports Record Fourth-Quarter and Full-Year Revenues
Simulations Plus Awarded New Cooperative Agreement with FDA
Project to Support Enhancements to Company’s Industry-Leading GastroPlus™ Software
Simulations Plus Reports Third Quarter FY2015 Financial Results
Revenues up 58.9%, Net Income up 41.7%
Board declares dividend of $0.05/share
Simulations Plus Sets Date for 3rd Quarter 2015 Earnings Release and Conference Call
Conference call to be on Monday, July 13, 2015, at 4:15 p.m. EDT
Simulations Plus Releases ADMET Predictor Version 7.2
Enhances synergy between predicted properties and GastroPlus™ Version 9.0 modeling capabilities
Simulations Plus Releases GastroPlus Version 9.0
Important new features expand market for flagship software product
Simulations Plus Augments Marketing and Sales Organization with Addition of Seasoned Scientist
Dr. Michael Lawless to transition to Marketing and Sales Team.
Dr. Vijay Gombar joins the Company as leader of the Cheminformatics Studies Team.
Simulations Plus Reports Second Quarter FY2015 Financial Results
Final report of second quarter financial results
Cognigen quarterly profits rise
Consolidated net revenues up 48.4%; second quarter net income increases 19.8%
Simulations Plus Reports First Quarter FY2015 Financial Results
Final report of first quarter financial results after Cognigen merger; net revenues up 54%; gross profit increased 41%
Simulations Plus Sets Date for 1st Quarter 2015 Earnings Release and Conference Call
Conference Call to be on Wednesday, January 14, at 4:15 PM ET
Simulations Plus Reports First Quarter FY2015 Preliminary Revenues
Preliminary revenues increase 50% to first quarter record $3.96 million